Evidence map›Paper›PMID 31008946›Full record

SynthesisMedicine2019

Role of tranexamic acid in nasal surgery: A systemic review and meta-analysis of randomized control trial.

Wei-Dong Ping, Qi-Ming Zhao, Hua-Feng Sun, Hai-Shan Lu, Fei Li

2 registry-linked trialsOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04754230 phase4completednot on this mapstarted 2021, after this paper: background citation

Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery

TypeinterventionalSponsorStanford UniversityRan2021 to 2022Enrolled40ConditionsChronic Sinusitis, Nasal Obstruction, Turbinate, Hypertrophy Mucous MembraneArmsTranexamic Acid 1,000 Mg/10 mL (100 Mg/mL) INTRAVEN VIAL (ML)
NCT04863339 phase2withdrawnnot on this mapstarted 2022, after this paper: background citation

Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery: A Double-Blind Randomized Controlled Trial

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2022 to 2022Enrolled0ConditionsPituitary Tumor, Blood Loss, SurgeryArmsTranexamic acid, Placebo
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Tranexamic acid in bleeding reduction and operative time of nasal surgeries: systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. A Comparison of Tranexamic Acid in Nasal Versus Sinus Surgeries: a Systematic Review and Meta-Analysis.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Perioperative management of endoscopic transsphenoidal pituitary surgery.World journal of otorhinolaryngology - head and neck surgery · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wei-Dong PingDepartment of Plastic and Reconstructive Surgery, Zhejiang Hospital.
Qi-Ming ZhaoDepartment of Plastic and Reconstructive Surgery, Zhejiang Hospital.
Hua-Feng SunDepartment of Plastic and Reconstructive Surgery, 903th Hospital of PLA, Hangzhou, Zhejiang, China.
Hai-Shan LuDepartment of Plastic and Reconstructive Surgery, 903th Hospital of PLA, Hangzhou, Zhejiang, China.
Fei LiDepartment of Plastic and Reconstructive Surgery, Zhejiang Hospital.
Zhejiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNasal surgeries (such as Functional Endoscopic Sinus Surgery, Rhinoplasty, and Septorhinoplasty) are popular procedures. But perioperative bleeding, eyelid edema, and periorbital ecchymosis remain problems. Tranexamic acid (TXA) is an antifibrinolytic, and it was used to reduce the perioperative bleeding. However, there is no enough evidence judging its safety and efficiency. Therefore, a meta-analysis is conducted by us to evaluate the role of TXA in patients undergoing nasal surgeries.

methodA search of the literature was performed until June 2018; the PubMed, Embase, Cochrane Central Register of Controlled Trials, and Google Scholar databases were searched for related articles using search strategy. Two authors independently assessed the methodological quality of the included studies and extracted data. Surgical information and postoperative outcomes were analyzed. Only randomized controlled trial (RCT) articles were included, and subgroup analysis was established to deal with heterogeneity. RevMan 5.3 software was selected to conduct the meta-analysis.

resultEleven RCTs were included in our meta-analysis. There were significant differences in blood loss (P < .001), surgical field quality (P < .001), edema rating of upper (P < .001) and lower (P < .001) eyelid, ecchymosis rating of upper (P < .001) and lower eyelid (P < .001) when comparing the TXA group to the placebo group. However, the difference in operation time (P = .57) was not significant between the two groups.

conclusionPerioperative TXA could reduce the blood loss and improve the quality of surgery field during nasal surgery, and it was helpful for reducing the edema and ecchymosis after nasal surgeries, but it has little influence in reducing the operation time.

Indexed as

Antifibrinolytic AgentsBlood Loss, SurgicalEcchymosisEdemaEyelid DiseasesHumansNasal Surgical ProceduresNoseOperative TimeRandomized Controlled Trials as TopicTranexamic AcidAntifibrinolytic AgentsTranexamic Acid

Identifiers

PMID31008946
PMCPMC6494350
OpenAlexW2936938185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.